ACUTA CAPITAL PARTNERS, LLC Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001582844

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q4 2023 · 39 positions · Total reported value $177.65M · Top-10 concentration 56.2% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 52.9% · 11 new · 7 cut · 0 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -16.4% · vs SPY -18.5% · Prev Value $143.49M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -8.3% · vs SPY -10.5% · Latest Value $126.75M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2023 13F filing, ACUTA CAPITAL PARTNERS, LLC disclosed 39 equity positions with a combined reported value of $177.65M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 56.2% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2023 were RYZB ($23.50M), CBAY ($11.62M), RCKT ($10.97M). By sector, the heaviest allocations are Health Care 54.9%, Industrials 5.5%. Versus the prior quarter, allocation shifted toward Other (+5.7pp), Industrials (+3.8pp) and away from Health Care (-9.4pp).

Versus the prior quarter, ACUTA CAPITAL PARTNERS, LLC opened 11 new positions, trimmed 7 and fully exited 0, a turnover rate of 52.9% of positions. The portfolio's overlap with the prior quarter was 49% of names.

The largest new positions opened in Q4 2023 were TRML ($6.07M), OCUL ($5.84M), RVMD ($4.59M).

Of the 8 positions fully exited versus the prior quarter, the largest were VTYX ($7.13M), SNDX ($4.31M), ALKS ($3.54M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2023)

  • TRML TOURMALINE BIO INC · $6.07M
  • OCUL OCULAR THERAPEUTIX INC · $5.84M
  • RVMD REVOLUTION MEDICINES INC · $4.59M
  • ACLX ARCELLX IN · $4.27M
  • APLT APPLIED THERAPEUTICS INC · $1.76M
  • FDMT 4D MOLECULAR THERAPEUTICS IN · $1.51M
  • INSM INSMED INC · $914.21K
  • ARGX ARGENX SE · $913.03K

Fully Exited (vs previous quarter)

  • VTYX VENTYX BIOSCIENCES INC · prev qtr: $7.13M
  • SNDX SYNDAX PHARMACEUTICALS INC · prev qtr: $4.31M
  • ALKS ALKERMES PLC · prev qtr: $3.54M
  • IKNA IKENA ONCOLOGY INC · prev qtr: $2.39M
  • OLMA OLEMA PHARMACEUTICALS INC · prev qtr: $1.89M
  • REPL REPLIMUNE GROUP INC · prev qtr: $1.77M
  • KRON KRONOS BIO INC · prev qtr: $934.36K
  • ACRS ACLARIS THERAPEUTICS INC · prev qtr: $833.59K

Insider Transactions (Form 4)

Latest ACUTA CAPITAL PARTNERS, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Acuta Capital Partners, based in Redwood City, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 23 positions worth $143.49M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: REDWOOD CITY, CA, United States
  • SEC registration: 801-136966 (status: Approved), registered 2026-09-09
  • Regulatory AUM (Form ADV): $172.53M as of 2026-06-30
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 2 hedge funds
  • Website: acutacapital.com

Portfolio Structure

  • 23 positions · $143.49M reported value (Q2 2026)
  • Top 10 holdings = 73.7% of reported value
  • Largest position: PRAX (PRAXIS PRECISION MEDICINES I) at 19.3%
  • Average position size: $6.24M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 4 new, 7 added, 6 reduced, 7 exited
  • 6 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 54.9%
Other 39.5%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 378.07K $23.50M 13.23%
13.23%
Add
2 492.15K $11.62M 6.54%
6.54%
Add
3 366.01K $10.97M 6.17%
6.17%
Add
4 701.35K $10.09M 5.68%
5.68%
Hold
5 425.13K $9.82M 5.53%
5.53%
Add
6 117.37K $7.37M 4.15%
4.15%
Reduce
7 70.60K $6.81M 3.83%
3.83%
Add
8 299.64K $6.68M 3.76%
3.76%
Reduce
9 115.50K $6.67M 3.75%
3.75%
Reduce
10 3.59M $6.35M 3.58%
3.58%
Reduce
11 281.50K $6.13M 3.45%
3.45%
Add
12 231.88K $6.07M 3.42%
3.42%
New
13 1.31M $5.84M 3.29%
3.29%
New
14 2.37M $5.49M 3.09%
3.09%
Add
15 324.60K $5.21M 2.93%
2.93%
Add
16 119.49K $5.03M 2.83%
2.83%
Reduce
17 160.00K $4.59M 2.58%
2.58%
New
18 76.10K $4.56M 2.56%
2.56%
Reduce
19 77.00K $4.27M 2.41%
2.41%
New
20 1.85M $3.74M 2.10%
2.10%
Hold
21 555.26K $3.60M 2.03%
2.03%
Hold
22 87.50K $3.11M 1.75%
1.75%
Reduce
23 69.40K $2.75M 1.55%
1.55%
Reduce
24 132.00K $2.70M 1.52%
1.52%
Add
25 147.84K $1.97M 1.11%
1.11%
Add
26 232.25K $1.89M 1.06%
1.06%
Add
27 525.10K $1.76M 0.99%
0.99%
New
28 123.88K $1.71M 0.96%
0.96%
Add
29 74.50K $1.51M 0.85%
0.85%
New
30 354.17K $1.47M 0.83%
0.83%
Hold
31 477.50K $1.32M 0.74%
0.74%
Add
32 29.50K $914.21K 0.52%
0.52%
New
33 2.40K $913.03K 0.51%
0.51%
New
34 19.00K $377.72K 0.21%
0.21%
New
35 10.00K $365.00K 0.20%
0.20%
New
36 38.14K $303.58K 0.17%
0.17%
Reduce
37 8.87K $122.81K 0.07%
0.07%
New
38 1.00K $22.50K 0.01%
0.01%
New
39 90.83K $5.45K 0.00%
0.00%
Hold

FAQ

What did ACUTA CAPITAL PARTNERS, LLC buy in 2023-Q4?

In its 2023-Q4 13F filing, ACUTA CAPITAL PARTNERS, LLC reported 39 equity positions worth $177.65M in aggregate; its largest disclosed positions were RYZB ($23.50M), CBAY ($11.62M), RCKT ($10.97M).

How large is ACUTA CAPITAL PARTNERS, LLC's portfolio?

ACUTA CAPITAL PARTNERS, LLC reported $177.65M of long equity holdings across 39 positions as of 2023-Q4. Top-10 holdings account for 56.2% of reported value.

What is ACUTA CAPITAL PARTNERS, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/acuta-capital-partners/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →